Logo image of CRBN.AS

CORBION NV (CRBN.AS) Stock Fundamental Analysis

Europe - AMS:CRBN - NL0010583399 - Common Stock

17.97 EUR
-0.44 (-2.39%)
Last: 11/14/2025, 5:29:59 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to CRBN. CRBN was compared to 67 industry peers in the Chemicals industry. Both the profitability and the financial health of CRBN get a neutral evaluation. Nothing too spectacular is happening here. CRBN is valued quite cheap, while showing a decent growth score. This is a good combination! This makes CRBN very considerable for value investing!


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

CRBN had positive earnings in the past year.
CRBN had a positive operating cash flow in the past year.
In the past 5 years CRBN has always been profitable.
Each year in the past 5 years CRBN had a positive operating cash flow.
CRBN.AS Yearly Net Income VS EBIT VS OCF VS FCFCRBN.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M

1.2 Ratios

CRBN has a Return On Assets of 4.55%. This is in the better half of the industry: CRBN outperforms 71.64% of its industry peers.
CRBN has a better Return On Equity (9.12%) than 67.16% of its industry peers.
CRBN has a Return On Invested Capital of 9.19%. This is in the better half of the industry: CRBN outperforms 77.61% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CRBN is in line with the industry average of 7.01%.
The 3 year average ROIC (6.62%) for CRBN is below the current ROIC(9.19%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.55%
ROE 9.12%
ROIC 9.19%
ROA(3y)7.34%
ROA(5y)6.93%
ROE(3y)16.91%
ROE(5y)15.8%
ROIC(3y)6.62%
ROIC(5y)7.13%
CRBN.AS Yearly ROA, ROE, ROICCRBN.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

The Profit Margin of CRBN (5.11%) is better than 64.18% of its industry peers.
In the last couple of years the Profit Margin of CRBN has grown nicely.
The Operating Margin of CRBN (8.68%) is better than 64.18% of its industry peers.
In the last couple of years the Operating Margin of CRBN has declined.
CRBN has a Gross Margin (26.10%) which is comparable to the rest of the industry.
CRBN's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 8.68%
PM (TTM) 5.11%
GM 26.1%
OM growth 3Y1.69%
OM growth 5Y-4.15%
PM growth 3Y26.84%
PM growth 5Y41.37%
GM growth 3Y-0.41%
GM growth 5Y-2.31%
CRBN.AS Yearly Profit, Operating, Gross MarginsCRBN.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

5

2. Health

2.1 Basic Checks

CRBN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
CRBN has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, CRBN has less shares outstanding
The debt/assets ratio for CRBN has been reduced compared to a year ago.
CRBN.AS Yearly Shares OutstandingCRBN.AS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
CRBN.AS Yearly Total Debt VS Total AssetsCRBN.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

An Altman-Z score of 2.74 indicates that CRBN is not a great score, but indicates only limited risk for bankruptcy at the moment.
CRBN has a better Altman-Z score (2.74) than 64.18% of its industry peers.
The Debt to FCF ratio of CRBN is 4.95, which is a neutral value as it means it would take CRBN, 4.95 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 4.95, CRBN is in the better half of the industry, outperforming 76.12% of the companies in the same industry.
A Debt/Equity ratio of 0.39 indicates that CRBN is not too dependend on debt financing.
The Debt to Equity ratio of CRBN (0.39) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.39
Debt/FCF 4.95
Altman-Z 2.74
ROIC/WACC1.43
WACC6.43%
CRBN.AS Yearly LT Debt VS Equity VS FCFCRBN.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

A Current Ratio of 1.21 indicates that CRBN should not have too much problems paying its short term obligations.
With a Current ratio value of 1.21, CRBN is not doing good in the industry: 80.60% of the companies in the same industry are doing better.
CRBN has a Quick Ratio of 1.21. This is a bad value and indicates that CRBN is not financially healthy enough and could expect problems in meeting its short term obligations.
CRBN has a worse Quick ratio (0.60) than 88.06% of its industry peers.
Industry RankSector Rank
Current Ratio 1.21
Quick Ratio 0.6
CRBN.AS Yearly Current Assets VS Current LiabilitesCRBN.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

4

3. Growth

3.1 Past

The earnings per share for CRBN have decreased strongly by -68.99% in the last year.
The Earnings Per Share has been growing by 49.47% on average over the past years. This is a very strong growth
Looking at the last year, CRBN shows a small growth in Revenue. The Revenue has grown by 2.95% in the last year.
Measured over the past years, CRBN shows a small growth in Revenue. The Revenue has been growing by 5.70% on average per year.
EPS 1Y (TTM)-68.99%
EPS 3Y34.95%
EPS 5Y49.47%
EPS Q2Q%-74.51%
Revenue 1Y (TTM)2.95%
Revenue growth 3Y6.35%
Revenue growth 5Y5.7%
Sales Q2Q%1.33%

3.2 Future

The Earnings Per Share is expected to grow by 13.71% on average over the next years. This is quite good.
Based on estimates for the next years, CRBN will show a small growth in Revenue. The Revenue will grow by 0.11% on average per year.
EPS Next Y36.6%
EPS Next 2Y21.96%
EPS Next 3Y18.01%
EPS Next 5Y13.71%
Revenue Next Year-1.8%
Revenue Next 2Y0.45%
Revenue Next 3Y1.67%
Revenue Next 5Y0.11%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CRBN.AS Yearly Revenue VS EstimatesCRBN.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B
CRBN.AS Yearly EPS VS EstimatesCRBN.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5

7

4. Valuation

4.1 Price/Earnings Ratio

CRBN is valuated correctly with a Price/Earnings ratio of 16.04.
Based on the Price/Earnings ratio, CRBN is valued a bit cheaper than the industry average as 70.15% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 25.89, CRBN is valued a bit cheaper.
With a Price/Forward Earnings ratio of 12.00, CRBN is valued correctly.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CRBN indicates a rather cheap valuation: CRBN is cheaper than 82.09% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 34.59, CRBN is valued rather cheaply.
Industry RankSector Rank
PE 16.04
Fwd PE 12
CRBN.AS Price Earnings VS Forward Price EarningsCRBN.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150 200 250

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CRBN is valued a bit cheaper than 68.66% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, CRBN is valued cheaply inside the industry as 94.03% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 10.49
EV/EBITDA 7.74
CRBN.AS Per share dataCRBN.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of CRBN may justify a higher PE ratio.
A more expensive valuation may be justified as CRBN's earnings are expected to grow with 18.01% in the coming years.
PEG (NY)0.44
PEG (5Y)0.32
EPS Next 2Y21.96%
EPS Next 3Y18.01%

6

5. Dividend

5.1 Amount

CRBN has a Yearly Dividend Yield of 3.63%. Purely for dividend investing, there may be better candidates out there.
CRBN's Dividend Yield is a higher than the industry average which is at 3.26.
CRBN's Dividend Yield is rather good when compared to the S&P500 average which is at 2.36.
Industry RankSector Rank
Dividend Yield 3.63%

5.2 History

The dividend of CRBN has a limited annual growth rate of 5.02%.
Dividend Growth(5Y)5.02%
Div Incr Years1
Div Non Decr Years5
CRBN.AS Yearly Dividends per shareCRBN.AS Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

56.19% of the earnings are spent on dividend by CRBN. This is a bit on the high side, but may be sustainable.
The dividend of CRBN is growing, but earnings are growing more, so the dividend growth is sustainable.
DP56.19%
EPS Next 2Y21.96%
EPS Next 3Y18.01%
CRBN.AS Yearly Income VS Free CF VS DividendCRBN.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M
CRBN.AS Dividend Payout.CRBN.AS Dividend Payout, showing the Payout Ratio.CRBN.AS Dividend Payout.PayoutRetained Earnings

CORBION NV

AMS:CRBN (11/14/2025, 5:29:59 PM)

17.97

-0.44 (-2.39%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)07-31 2025-07-31
Earnings (Next)N/A N/A
Inst Owners91.06%
Inst Owner ChangeN/A
Ins Owners0.22%
Ins Owner ChangeN/A
Market Cap1.05B
Revenue(TTM)1.30B
Net Income(TTM)66.20M
Analysts77.14
Price Target22.79 (26.82%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.63%
Yearly Dividend0.71
Dividend Growth(5Y)5.02%
DP56.19%
Div Incr Years1
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2%
PT rev (3m)-2.54%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-1.41%
EPS NY rev (3m)-12.1%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.83%
Revenue NY rev (3m)-1.51%
Valuation
Industry RankSector Rank
PE 16.04
Fwd PE 12
P/S 0.81
P/FCF 10.49
P/OCF 6.21
P/B 1.44
P/tB 1.65
EV/EBITDA 7.74
EPS(TTM)1.12
EY6.23%
EPS(NY)1.5
Fwd EY8.33%
FCF(TTM)1.71
FCFY9.53%
OCF(TTM)2.89
OCFY16.1%
SpS22.26
BVpS12.47
TBVpS10.88
PEG (NY)0.44
PEG (5Y)0.32
Graham Number17.72
Profitability
Industry RankSector Rank
ROA 4.55%
ROE 9.12%
ROCE 10.92%
ROIC 9.19%
ROICexc 9.57%
ROICexgc 10.55%
OM 8.68%
PM (TTM) 5.11%
GM 26.1%
FCFM 7.7%
ROA(3y)7.34%
ROA(5y)6.93%
ROE(3y)16.91%
ROE(5y)15.8%
ROIC(3y)6.62%
ROIC(5y)7.13%
ROICexc(3y)7.16%
ROICexc(5y)7.83%
ROICexgc(3y)8.31%
ROICexgc(5y)9.44%
ROCE(3y)7.87%
ROCE(5y)8.47%
ROICexgc growth 3Y0.82%
ROICexgc growth 5Y-11.84%
ROICexc growth 3Y3.78%
ROICexc growth 5Y-8.06%
OM growth 3Y1.69%
OM growth 5Y-4.15%
PM growth 3Y26.84%
PM growth 5Y41.37%
GM growth 3Y-0.41%
GM growth 5Y-2.31%
F-Score6
Asset Turnover0.89
Health
Industry RankSector Rank
Debt/Equity 0.39
Debt/FCF 4.95
Debt/EBITDA 1.43
Cap/Depr 81.01%
Cap/Sales 5.3%
Interest Coverage 7.03
Cash Conversion 85.4%
Profit Quality 150.76%
Current Ratio 1.21
Quick Ratio 0.6
Altman-Z 2.74
F-Score6
WACC6.43%
ROIC/WACC1.43
Cap/Depr(3y)194.04%
Cap/Depr(5y)192.31%
Cap/Sales(3y)11.51%
Cap/Sales(5y)11.48%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-68.99%
EPS 3Y34.95%
EPS 5Y49.47%
EPS Q2Q%-74.51%
EPS Next Y36.6%
EPS Next 2Y21.96%
EPS Next 3Y18.01%
EPS Next 5Y13.71%
Revenue 1Y (TTM)2.95%
Revenue growth 3Y6.35%
Revenue growth 5Y5.7%
Sales Q2Q%1.33%
Revenue Next Year-1.8%
Revenue Next 2Y0.45%
Revenue Next 3Y1.67%
Revenue Next 5Y0.11%
EBIT growth 1Y54.53%
EBIT growth 3Y8.15%
EBIT growth 5Y1.31%
EBIT Next Year132.41%
EBIT Next 3Y36.9%
EBIT Next 5Y21.13%
FCF growth 1Y171.85%
FCF growth 3YN/A
FCF growth 5Y21.2%
OCF growth 1Y118.83%
OCF growth 3Y101.81%
OCF growth 5Y9.98%

CORBION NV / CRBN.AS FAQ

What is the fundamental rating for CRBN stock?

ChartMill assigns a fundamental rating of 5 / 10 to CRBN.AS.


Can you provide the valuation status for CORBION NV?

ChartMill assigns a valuation rating of 7 / 10 to CORBION NV (CRBN.AS). This can be considered as Undervalued.


What is the profitability of CRBN stock?

CORBION NV (CRBN.AS) has a profitability rating of 6 / 10.


Can you provide the PE and PB ratios for CRBN stock?

The Price/Earnings (PE) ratio for CORBION NV (CRBN.AS) is 16.04 and the Price/Book (PB) ratio is 1.44.


Can you provide the dividend sustainability for CRBN stock?

The dividend rating of CORBION NV (CRBN.AS) is 6 / 10 and the dividend payout ratio is 56.19%.